CNS Pharmaceuticals Quote - CNSP

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

0.106

Bid

0.1069

Ask

0.109

Volume

5,028

0.00 Day's Range 0.00

0.0955 52 Week Range 70.00

Market Cap

6.094M

Previous Close

0.109

Open

Last Trade

0.1089

Last Trade Time

05:52:12

Financial Volume

VWAP

Average Volume (3m)

16,638,682

Shares Outstanding

57,486,706

Dividend Yield

PE Ratio

-0.34

Earnings Per Share (EPS)

-0.33

Revenue

Net Profit

-18.85M

CNS Pharmaceuticals Inc is a preclinical stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of ... CNS Pharmaceuticals Inc is a preclinical stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.cnspharma.com

Headquarters

Carson City, Nevada, USA

Founded

CNS Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CNSP. The last closing price for CNS Pharmaceuticals was US$0.11. Over the last year, CNS Pharmaceuticals shares have traded in a share price range of US$ 0.0955 to US$ 70.00.

CNS Pharmaceuticals currently has 57,486,706 shares outstanding. The market capitalization of CNS Pharmaceuticals is US$6.27 million. CNS Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.34.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.001	0.952380952381	0.105	0.125	0.1008	7028990	0.11094192	CS
4	-0.005	-4.5045045045	0.111	0.125	0.0957	3841996	0.10916674	CS
12	-0.029	-21.4814814815	0.135	0.3699	0.0957	16638682	0.13493007	CS
26	-1.884	-94.6733668342	1.99	4	0.0955	10610304	0.24933069	CS
52	-57.394	-99.8156521739	57.5	70	0.0955	5707274	0.81624431	CS
156	-1290.344	-99.9917858112	1290.45	2070	0.0955	2472458	80.90892698	CS
260	-5774.894	-99.9981645022	5775	8430	0.0955	1694566	535.03286195	CS

CNSP - Frequently Asked Questions (FAQ)

What is the current CNS Pharmaceuticals share price?

The current share price of CNS Pharmaceuticals is US$ 0.106

How many CNS Pharmaceuticals shares are in issue?

CNS Pharmaceuticals has 57,486,706 shares in issue

What is the market cap of CNS Pharmaceuticals?

The market capitalisation of CNS Pharmaceuticals is USD 6.27M

What is the 1 year trading range for CNS Pharmaceuticals share price?

CNS Pharmaceuticals has traded in the range of US$ 0.0955 to US$ 70.00 during the past year

What is the PE ratio of CNS Pharmaceuticals?

The price to earnings ratio of CNS Pharmaceuticals is -0.34

What is the reporting currency for CNS Pharmaceuticals?

CNS Pharmaceuticals reports financial results in USD

What is the latest annual profit for CNS Pharmaceuticals?

The latest annual profit of CNS Pharmaceuticals is USD -18.85M

What is the registered address of CNS Pharmaceuticals?

The registered address for CNS Pharmaceuticals is 112 NORTH CURRY STREET, CARSON CITY, NEVADA, 89703

What is the CNS Pharmaceuticals website address?

The website address for CNS Pharmaceuticals is www.cnspharma.com

Which industry sector does CNS Pharmaceuticals operate in?

CNS Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AVGRAvinger Inc	US$ 1.95 (203.55%)	39.93M
BAOSBaosheng Media Group Holdings Ltd	US$ 4.17 (141.04%)	10.45M
ATNF180 Life Sciences Corporation	US$ 3.67 (96.26%)	7.47M
TIVCTivic Health Systems Inc	US$ 0.411 (83.16%)	34.4M
CMNDClearmind Medicine Inc	US$ 1.97 (61.48%)	3.75M
SLGLSol Gel Technologies Ltd	US$ 0.905 (-45.15%)	419.72k
BTFValkyrie ETF Trust II CoinShares Bitcoin and Ether Stratagy ETF	US$ 14.95 (-32.72%)	1.07k
GLDDGreat Lakes Dredge and Dock Corporation	US$ 9.01 (-21.96%)	2
KALVKalVista Pharmaceuticals Inc	US$ 7.00 (-20.72%)	168
ALMSAlumis Inc	US$ 6.71 (-19.83%)	1
SVMHSRIVARU Holding Ltd	US$ 0.0347 (23.93%)	132.45M
AVGRAvinger Inc	US$ 1.95 (203.55%)	39.93M
TIVCTivic Health Systems Inc	US$ 0.411 (83.16%)	34.4M
LAESSEALSQ Corporation	US$ 6.09 (24.29%)	14.94M
AUUDAuddia Inc	US$ 0.6176 (28.99%)	10.51M